News
BMS gets FDA nod for Opdivo as first adjuvant bladder cancer...
Bristol Myers Squibb has scored a win in its drive to get Opdivo into earlier lines of cancer therapy, getting FDA approval for the drug for post-surgical treatment of invasive bladder canc
